Numerous previous studies reported that inflammatory biomarkers, including C-reactive protein (CRP) and interleukin-6 (IL-6), were independently associated with overall survival in (from only 7 to 474) patients with pancreatic cancer [6,7,8,9,10,11]. This evidence concerns the gene IL6 and pancreatic neoplasm.